HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term ...
Recent medical research reveals that early HIV symptoms often masquerade as common illnesses, leading many to delay seeking medical attention. Dr. Sarah Chen, infectious disease specialist at ...
To reduce care disparities and prevent them from exacerbating among people living with HIV who have long COVID, education and ...
Tiamat Legion Medusa from Texas, who was born Richard Hernandez, had a dream about a snake bite, which they believe turned ...
Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But ...
Global HIV Study Finds That Cardiovascular Risk Models ... researchers have determined that a protein called NF-kB c-Rel can intensify the symptoms of psoriasis when activated by signals from ...
Severe mpox and long-term sequelae such as severe scarring were more likely to occur among HIV-positive patients with detectable viral loads and low CD4 counts.
Similar observations were shared by clinicians at Helen Joseph Hospital, in Johannesburg, who reported: “We used to routinely test and start treatment for inpatients with HIV symptoms.
One of the hot topics at this year's Conference on Retroviruses and Opportunistic Infections will be long COVID: potential ...
To learn more, please visit www.reprievetrial.org.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback